Cargando…

GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1

BACKGROUND: Glutathione Peroxidase 4 (GPX4) is a key protein that inhibits ferroptosis. However, its biological regulation and mechanism in endometrial cancer (EC) have not been reported in detail. METHODS: The expression of GPX4 in EC tissues was determined by TCGA databases, qRT-PCR, Western blot,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Sitian, Yu, Zhicheng, Shi, Rui, An, Lanfen, Zhang, Qi, Zhang, Qian, Zhang, Tangansu, Zhang, Jun, Wang, Hongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373394/
https://www.ncbi.nlm.nih.gov/pubmed/35962333
http://dx.doi.org/10.1186/s12885-022-09986-3
_version_ 1784767588492902400
author Wei, Sitian
Yu, Zhicheng
Shi, Rui
An, Lanfen
Zhang, Qi
Zhang, Qian
Zhang, Tangansu
Zhang, Jun
Wang, Hongbo
author_facet Wei, Sitian
Yu, Zhicheng
Shi, Rui
An, Lanfen
Zhang, Qi
Zhang, Qian
Zhang, Tangansu
Zhang, Jun
Wang, Hongbo
author_sort Wei, Sitian
collection PubMed
description BACKGROUND: Glutathione Peroxidase 4 (GPX4) is a key protein that inhibits ferroptosis. However, its biological regulation and mechanism in endometrial cancer (EC) have not been reported in detail. METHODS: The expression of GPX4 in EC tissues was determined by TCGA databases, qRT-PCR, Western blot, and immunohistochemistry (IHC). The effects of GPX4 on EC cell proliferation, migration, apoptosis, and tumorigenesis were studied in vivo and in vitro. In addition, ETS Transcription Factor ELK1 (ELK1) was identified by bioinformatics methods, dual-luciferase reporter assay, and chromatin immunoprecipitation (ChIP). Pearson correlation analysis was used to evaluate the association between ELK1 and GPX4 expression. RESULTS: The expression of GPX4 was significantly up-regulated in EC tissues and cell lines. Silencing GPX4 significantly inhibited the proliferation, migration ability, induced apoptosis, and arrested the cell cycle of Ishikawa and KLE cells. Knockdown of GPX4 accumulated intracellular ferrous iron and ROS, disrupted MMP, and increased MDA levels. The xenograft tumor model also showed that GPX4 knockdown markedly reduced tumor growth in mice. Mechanically, ELK1 could bind to the promoter of GPX4 to promote its transcription. In addition, the expression of ELK1 in EC was positively correlated with GPX4. Rescue experiments confirmed that GPX4 knockdown could reverse the strengthens of cell proliferation and migration ability and the lower level of Fe(2+) and MDA caused by upregulating ELK1. CONCLUSION: The results of the present study suggest that ELK1 / GPX4 axis plays an important role in the progress of EC by promoting the malignant biological behavior and inducing ferroptosis of EC cells, which provides evidence for investigating the potential therapeutic strategies of endometrial cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09986-3.
format Online
Article
Text
id pubmed-9373394
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93733942022-08-13 GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1 Wei, Sitian Yu, Zhicheng Shi, Rui An, Lanfen Zhang, Qi Zhang, Qian Zhang, Tangansu Zhang, Jun Wang, Hongbo BMC Cancer Research BACKGROUND: Glutathione Peroxidase 4 (GPX4) is a key protein that inhibits ferroptosis. However, its biological regulation and mechanism in endometrial cancer (EC) have not been reported in detail. METHODS: The expression of GPX4 in EC tissues was determined by TCGA databases, qRT-PCR, Western blot, and immunohistochemistry (IHC). The effects of GPX4 on EC cell proliferation, migration, apoptosis, and tumorigenesis were studied in vivo and in vitro. In addition, ETS Transcription Factor ELK1 (ELK1) was identified by bioinformatics methods, dual-luciferase reporter assay, and chromatin immunoprecipitation (ChIP). Pearson correlation analysis was used to evaluate the association between ELK1 and GPX4 expression. RESULTS: The expression of GPX4 was significantly up-regulated in EC tissues and cell lines. Silencing GPX4 significantly inhibited the proliferation, migration ability, induced apoptosis, and arrested the cell cycle of Ishikawa and KLE cells. Knockdown of GPX4 accumulated intracellular ferrous iron and ROS, disrupted MMP, and increased MDA levels. The xenograft tumor model also showed that GPX4 knockdown markedly reduced tumor growth in mice. Mechanically, ELK1 could bind to the promoter of GPX4 to promote its transcription. In addition, the expression of ELK1 in EC was positively correlated with GPX4. Rescue experiments confirmed that GPX4 knockdown could reverse the strengthens of cell proliferation and migration ability and the lower level of Fe(2+) and MDA caused by upregulating ELK1. CONCLUSION: The results of the present study suggest that ELK1 / GPX4 axis plays an important role in the progress of EC by promoting the malignant biological behavior and inducing ferroptosis of EC cells, which provides evidence for investigating the potential therapeutic strategies of endometrial cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09986-3. BioMed Central 2022-08-12 /pmc/articles/PMC9373394/ /pubmed/35962333 http://dx.doi.org/10.1186/s12885-022-09986-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wei, Sitian
Yu, Zhicheng
Shi, Rui
An, Lanfen
Zhang, Qi
Zhang, Qian
Zhang, Tangansu
Zhang, Jun
Wang, Hongbo
GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
title GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
title_full GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
title_fullStr GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
title_full_unstemmed GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
title_short GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
title_sort gpx4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by elk1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373394/
https://www.ncbi.nlm.nih.gov/pubmed/35962333
http://dx.doi.org/10.1186/s12885-022-09986-3
work_keys_str_mv AT weisitian gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT yuzhicheng gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT shirui gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT anlanfen gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT zhangqi gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT zhangqian gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT zhangtangansu gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT zhangjun gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1
AT wanghongbo gpx4suppressesferroptosistopromotemalignantprogressionofendometrialcarcinomaviatranscriptionalactivationbyelk1